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doi:10.1Objective: Osteopontin is a multifunctional phosphoprotein with an important but poorly understood role in
non–small cell lung cancer pathogenesis. We hypothesize that osteopontin isoforms (OPNa, OPNb, and
OPNc) have divergent roles in non–small-cell lung cancer angiogenesis and divergent impact on vascular endo-
thelial growth factor secretion.
Methods: We examined mRNA expression using reverse transcriptase-polymerase chain reaction primers for
3 osteopontin isoforms in non–small-cell lung cancer and immortalized bronchial epithelial cell lines, and
correlated expression with osteopontin secretion into media detected by enzyme-linked immunosorbent assay.
Angiogenic properties conferred by osteopontin isoforms were evaluated by transfecting cDNA plasmids specific
to each isoform and controls into non–small-cell lung cancer cell lines, H153 and H358 (low endogenous osteo-
pontin) and A549 and H460 (high endogenous osteopontin), analyzing conditioned media on a bovine capillary
endothelial platform, and measuring vascular endothelial growth factor levels by enzyme-linked immunosorbent
assay.
Results: OPNa mRNA expression correlated with osteopontin secretion in cell lines (r ¼ 0.912, P ¼ .0006).
OPNa overexpression significantly increased tubule length compared with controls, OPNb had a similar, but
less pronounced effect, and OPNc significantly decreased tubule length compared with controls in each cell
line. OPNa overexpression was associated with significant increases in vascular endothelial growth factor secre-
tion, whereas OPNb had no effect and OPNc overexpression was associated with significant decreases in vascular
endothelial growth factor compared with controls in each cell line.
Conclusion: We demonstrated divergent effects of osteopontin isoforms on non–small-cell lung cancer angio-
genesis and vascular endothelial growth factor secretion. OPNa overexpression was associated with increased
bovine capillary endothelial tubule length and vascular endothelial growth factor secretion, whereas OPNc
was associated with decreases in both. These findings may lead to therapeutic strategies for selective isoform
inhibition in non–small cell lung cancer. (J Thorac Cardiovasc Surg 2010;139:1587-93)/B
SOsteopontin (OPN) is a multifunctional phosphoprotein
with a significant role in the pathogenesis of non–small-
cell lung cancer (NSCLC). In NSCLC, elevated OPN levels
in tumors and serum are associated with poor patient prog-
nosis and increased risk for recurrence.1 NSCLC cell lines
that natively express OPN have greater metastatic potential
and invasive behavior,2 but the molecular pathways for
OPN tumorigenicity are incompletely understood. Three
human mRNA splice variants of OPN have been identified.
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Tosteopontin-b (OPNb) is defined by a deletion at exon-5,
and osteopontin-c (OPNc) is defined by a deletion at
exon-4. Expression and function of the individual isoforms
in clinical NSCLC samples or tumor model systems have
not been reported.
Increased angiogenesis is essential for growth and metas-
tasis of solid tumors. In NSCLC, an important relationship
exists between microvessel development and progression
to invasive disease.3-5 Tumor microvessel formation is de-
pendent on adhesive interactions between tumor cells and
the extracellular matrix, and is essential to establish conduits
for nutrient delivery. Increased microvessel development
has also been directly correlated with tumor maturation
and is an independent risk factor for the development of met-
astatic disease.5,6
Vascular endothelial growth factor (VEGF) is a potent
angiogenic and mitogenic protein that plays a central role
in tumor neovascularization. In NSCLC, VEGF levels corre-
late directly with clinical outcome.7,8 VEGF also has an es-
tablished role in the progression of tumor invasion caused by
receptor stimulated capillary in-growth and microvessel for-
mation.4,9 Binding of VEGF to endothelial cell surface
receptors increases migration and proliferation. VEGFdiovascular Surgery c Volume 139, Number 6 1587
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S15Abbreviations and Acronyms88BCE ¼ bThe Jovine capillary endothelialbp ¼ base pair
DMEM ¼ Dulbecco’s Modified Eagle Medium
ELISA ¼ enzyme-linked immunosorbent assay
NSCLC ¼ non–small-cell lung cancer
OPN ¼ osteopontin
RT-PCR ¼ reverse transcriptase-polymerase chain
reactionVEGF ¼ vascular endothelial growth factorfurther supports the growth and stabilization of new blood
vessels, which facilitates tumor expansion and formation
of metastasis.10 Interruption of this pathway via VEGF inhi-
bition results in endothelial cell apoptosis and restricted
tumor progression.10
VEGF and OPN are frequently expressed simultaneously
during angiogenesis, both by tumor cells and by activated
macrophages associated with ischemia and necrosis.11 Co-
expression of VEGF and OPN is associated with enhanced
tumor microvessel development and is a marker for poor
prognosis in early-stage NSCLC.12 VEGF-mediated angio-
genesis is significantly increased by concurrent OPN stimu-
lation of endothelial cells.10 The aim of this investigation is
to evaluate the effect of individual OPN isoforms (OPNa,
OPNb, and OPNc) on tumor-associated angiogenic proper-
ties of NSCLC and to determine whether concurrent
VEGF expression and secretion is affected in an isoform-
specific manner.
MATERIALS AND METHODS
Seven human lung cancer cell lines (A549, H358, H153, H157, H1299,
H460, and Calu-3) were obtained from American Type Tissue Collection
(Manassas, VA). Two human immortalized bronchial endothelial cell lines,
Beas2 B and HKT3, were received as gifts (Dr John Minna, University
Texas Southwestern, Dallas, Tex). Cell lines were maintained in culture
in Dulbecco’s Modified Eagle Medium (DMEM) (Invitrogen, Grand Island,
NY) with 10% fetal bovine serum (Invitrogen) at 37C, 5% CO2.
Reverse transcriptase-polymerase chain reaction (RT-PCR) primers
were designed on the basis of the 3 National Cancer for Biotechnology
Information GeneBank sequences to be inclusive of the regions of exon-4
and exon-5 at the N-terminus, which are deleted from OPNc and OPNb,
respectively. The resulting primers, 50TTGCAGTGATTTGCTTTTGC-30
(sense) and 50GTCAATGGAGTCCTGGCTGT-30 (antisense), amplify
a 305-base pair (bp) product from OPNa, a 263-bp product from OPNb,
and a 224-bp product from OPNc in a single reaction, which are separated
by electrophoresis.
With the use of these primers, we examined mRNA expression of OPN
by RT-PCR and correlated that with OPN secretion into media, detected by
enzyme-linked immunosorbent assay (ELISA) (IBL, Gunma, Japan) in the
series of 9 cell lines. Conditioned media was collected from cultures after 72
hours in serum-free conditions, and mRNA was isolated from the cell lines
using the RNEasy mini kit (QIAGEN, Valencia, Calif). PCR amplification
was carried out in a total volume of 20 mL using the standard Invitrogen
PCR buffer system (Invitrogen, Carlsbad, Calif) and optimized concentra-ournal of Thoracic and Cardiovascular Surtions of MgCl2. The reactions were performed with denaturing for 15 sec-
onds at 94C, annealing for 30 seconds at 58C, and elongation for 30
seconds at 70C for a total of 40 cycles; the final extension was at 72C
for 5 minutes. RT-PCR products were analyzed by Tris-acetate EDTA aga-
rose (2% w/v) gel electrophoresis. The amplification of peptidylprolyl
isomerase A with primers 50-TCTGAGCACTGGAGAGAAAGG-30
(sense) and 50GGAAAACATGGAACCC-30 (antisense) served as controls
for equal loading and integrity of all PCR reactions.
We evaluated the functional impact of each OPN isoform by transfecting
cDNA plasmids specific to each isoform (Origene, Rockville, Md) into 4
NSCLC cell lines (H153, H358, A549, and H460). H153 and H358 cell
lines have low endogenous OPN expression, whereas A549 and H460
have high endogenous OPN expression. Plasmids were derived from sin-
gle-colony Escherichia coli culture and purified by silica chromatography.
The protein coding sequence of each clone matched the published National
Cancer for Biotechnology Information GeneBank NM references for each
OPN isoform. NSCLC cell lines were transfected using Lipofectamine2000
(Invitrogen) with either OPN isoform plasmid construct or pCMV empty
vector, which served as a control. A pooled population of cells was used
for RT-PCR and functional analysis.
Angiogenic properties were measured using an in vitro bovine capillary
endothelial (BCE) platform. BCE cells (Cell Applications Inc, San Diego,
Calif) were maintained on gelatin-coated, 10-cm plastic dishes in 10 mL
of endothelial growth media (Cell Applications, Inc), supplemented with
10% fetal bovine serum, 5 U/mL penicillin, and 5 mg/mL streptomycin
at 37C, 5% CO2. Cells were subcultured for 9 to 13 passages before com-
mencing experiments.
The BCE angiogenesis platform was performed as previously de-
scribed.13,14 In brief, BCE cells were trypsinized, washed in phosphate-
buffered saline, and resuspended in conditioned media harvested from
OPN isoform transfections and control cell lines at a concentration of
16,000 cells/100 mL. Diluted 1:100 Matrigel (Becton Dickinson, Bedford,
Mass) was used to coat 96-well plates. Plates were incubated at room tem-
perature for 1 hour and washed with phosphate-buffered saline. BCE cells in
conditioned media were suspended on the Matrigel platform in triplicates.
DMEM, DMEMþfibroblast growth factor (1 mg/100 mL) (R&D Systems,
Minneapolis, Minn), and DMEMþVEGF (2 mg/100 mL) (R&D Systems)
were used as controls. BCE cells were incubated with conditioned media on
the Matrigel platform for 18 hours at 37C, 5% CO2, and then stained with
0.05% crystal violet. Tubule length was measured under 103magnification
using a 9-grid measuring platform. The sum of all tubules within an 889 m2
area was measured in triplicate and compared between experimental cell
lines and controls. Tubules with a clear origin from an endothelial cell nu-
cleus were included in the measurement. Tubule length is reported as a mean
of total microns (m)  standard deviation.
We evaluated the impact of individual OPN isoforms on VEGF by mea-
suring protein secretion into media from the OPN isoform transfected cell
lines. Human VEGF ELISA Kits (R&D) were used to quantify VEGF secre-
tion into media (picograms/milliliter). Changes in OPN protein secretion as
a result of isoform overexpression were simultaneously evaluated by ELISA
(described above).
To explore the relationship between VEGF secretion and OPN-induced
mediators of endothelial cell proliferation, we used an Affymetrix Gene
Chip (Santa Clara, Calif) U133 Plus2 platform to evaluate gene expression
profiles in A549 (high endogenous OPN) with overexpression of OPNa,
OPNc, and pCMV controls. mRNA was used from the same population
of cells used in the BCE angiogenesis assays. Differences in VEGF expres-
sion identified in gene array were validated in all 4 cell lines by RT-PCR.
VEGF primers, 50CCTTGCTGCTCTACCTCCAC-30(sense) and
50ATCTGCATGGTGATGTTGGA-30(antisense), amplify a 280-bp prod-
uct. The RT-PCR protocol was performed as previously described.
A 2-sided Student t test was used to evaluate differences in BCE tubule
length and VEGF secretion between cell lines transfected with the individ-
ual OPN isoforms and empty vector controls. Statistics were performedgery c June 2010
Blasberg et al Evolving Technology/Basic Scienceusing the Statistical Package for the Social Sciences version 11.5 (SPSS Inc,
Chicago, Ill). Data are presented as mean  standard deviation.RESULTS
We noted a correlation between OPN mRNA expression
and OPN secretion in the series of lung cancer and bronchial
epithelial cell lines (r ¼ 0.9120; P ¼ .0006; confidence in-
terval, 0.6286–0.9816). Five cell lines (A549, H460,
H157, H1299, and Calu-3) had high endogenous OPN
mRNA expression and OPN secretion detected in condi-
tioned media. Two NSCLC cell lines (H153 and H358)
and the 2 bronchial epithelial cell lines (Beas2 Bs and
HKT3) had minimal endogenous OPN mRNA expression
and no detectable OPN secretion into media. OPNa, the
full-length isoform, was dominantly expressed in OPN-se-
creting cell lines. Concurrent OPNb expression was noted
in the same cell lines, but to a lesser extent than OPNa.
OPNc was not noted to be endogenously expressed in these
cell lines (Figure 1).
Validation of plasmid expression in each cell line is dem-
onstrated in Figure 2. Initial angiogenic experiments focused
on overexpression of the individual OPN isoforms in H153,
an NSCLC cell line with low endogenous OPN expression.
Conditioned media harvested from H153 cells with forced
overexpression of OPNa resulted in a significant increase
in BCE tubule length (1599.23 m  18.45) compared with
empty vector controls (725.02 m  12.75, P < .0001).
OPNb overexpression had a similar effect on tubule length
(1050.22 m  13.22, P< .0001). Conversely, media from
cells that overexpressed OPNc resulted in a significant de-
crease in tubule length compared with controls (523.05 m
 9.25, P< .0001) (Figure 3).
This divergent pattern of behavior with overexpression of
the individual OPN isoforms was validated in 3 additional
NSCLC cell lines: H358, with low endogenous OPN expres-
sion, and A549 and H460, both with high endogenous OPN
expression. In all 4 cell lines, the pattern of effect on tubule
length was consistent: Overexpression of OPNa signifi-FIGURE 1. OPN mRNA expression in human lung cancer and immortalized b
then separated by electrophoresis on 2% agarose gel. OPNa produces the 305-b
below the dominant band in A549, H157, Calu-3, H460, and H1299. OPNc am
these cell lines. Amplification of pCMV2 plasmid specific to each isoform serves
as control for equal loading. OPN expression correlates with OPN secretion as d
bronchial epithelial cells; adeno, adenocarcinoma; ELISA, enzyme-linked immun
cancer; OPN, osteopontin; PPIA, peptidylprolyl isomerase A; RT-PCR, reverse
The Journal of Thoracic and Carcantly increased BCE tubule length compared with controls,
overexpression of OPNb also significantly increased tubule
length but to a lesser extent than OPNa, and overexpression
of OPNc significantly decreased BCE tubule length com-
pared with controls (Figure 3). Empty vector controls from
A549 and H460 formed significantly longer tubules com-
pared with controls with low endogenous OPN (P <
.0001), most clearly demonstrated in bar graft depiction of
results from the BCE assay (Figure 4, A).
Overexpression of the individual OPN isoforms was also
associated with a divergent effect on VEGF secretion. OPNa
overexpression was associated with a significant increased
in VEGF secretion compared with controls in all 4 cell lines.
OPNc overexpression was associated with a significant de-
crease in VEGF secretion in all cell lines compared with con-
trols. However, OPNb overexpression was not associated
with significant alterations in VEGF secretion compared
with controls in any of the cell lines (Figure 4, B).
Overexpression of the individual OPN isoforms was also
associated with a divergent effect on OPN secretion. Over-
expression of OPNa and OPNb was associated with small
increases in the concentration of OPN protein in conditioned
media, but OPNc overexpression was associated with a sig-
nificant increase in OPN protein secretion in all 4 cell lines
(Figure 4, C).
Significant differences in downstream patterns of regula-
tion were noted on expression profiles of A549 overexpress-
ing OPNa and OPNc. Relative expression of VEGF was
increased 2-fold compared with controls with overexpres-
sion of OPNa and decreased 40% with overexpression of
OPNc. This pattern of divergent VEGF expression was val-
idated by RT-PCR in all 4 cell lines. We noted that control
cell lines with high endogenous OPN (A549 and H460)
had appreciably higher VEGF mRNA expression than con-
trol cell lines with low endogenous OPN expression (H153
and H358). In all cell lines, overexpression of OPNa was
associated with increased VEGF mRNA expression, most
appreciably in cell lines with low endogenous OPN, andronchial epithelial cells. Primers amplify each of the 3 isoforms, which are
p dominant band seen at the top. OPNb amplifies a 263-bp fragment seen
plifies a 224-bp fragment that migrates below the OPNb and is not seen in
as positive controls, and amplification of peptidylprolyl isomerase A serves
etected by ELISA after 72 hours in serum-free media. BrEpC, Immortalized
osorbent assay; SCLC, small-cell lung cancer; NSCLC, non–small-cell lung
transcriptase-polymerase chain reaction; N/A, not available.
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FIGURE 2. RT-PCR demonstrating forced expression of individual OPN
isoforms in 4 NSCLC cell lines. Pooled populations of transfected cells
were used in RT-PCR and angiogenesis assay. H153 and H358 have low
native OPN expression. A549 and H60 have high native OPN expression.
OPN, Osteopontin; PPIA, peptidylprolyl isomerase A.
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compared with controls, most appreciably in cell lines
with high endogenous OPN. OPNb overexpression, which
was not evaluated by gene array, seems to have a less con-
sistent impact on VEGF expression (Figure 5).FIGURE 3. Representative sections showing tubule formation and mean tubule
cultured in conditioned media collected from NSCLC cell lines transfected with
H358 have low native OPN expression, and A549 and H460 have high native OP
more tubule formation compared with controls. OPNb overexpression also signifi
a lesser extent then OPNa. OPNc overexpression resulted in a significant decrease
Osteopontin.
1590 The Journal of Thoracic and Cardiovascular SurDISCUSSION
OPN has been identified in a remarkable range of normal
and pathologic contexts.15 It is an important adhesive bone
matrix protein and plays a key role in immune cell recruit-
ment, wound healing, and tissue remodeling.16,17 Overex-
pression of OPN is also recognized in pathologic
conditions that involve inflammation, ischemia, and malig-
nancy. The importance of OPN in tumor pathogenesis is
highlighted in gene transfer experiments, in which transfec-
tion of OPN increases the malignant phenotype,18 and OPN
knock-out experiments with antisense oligonucleotides that
decrease malignant potential.19,20 OPN’s principle functions
are related to cell migration and adhesion, and are mediated
by integrin binding to its central and well-conserved RGD
(arginine-glycine-aspartate) domain. OPN is overexpressed
by immunohistochemistry in human NSCLC tumors com-
pared with surrounding normal lung paranchyma.2 In vitro
experiments demonstrate increased migration and invasion
by NSCLC cell lines that overexpress OPN.2 These data sug-
gest an important role for OPN in determining the metastatic
potential of NSCLC.
Increased angiogenesis is a key feature of malignant
transformation that allows for tumor growth and facilitates
tumor cell entry into the circulation.21 VEGF is a crucial
intermediate in this process, which acts via endothelial cell
activation, facilitating mitogenic and vascular permeabil-
ity-enhancing activities.3,4,7,9 Inhibition of VEGF decreases
tumor neovascularization and substantially inhibits primary
tumor growth.22 OPN has an established relationship with
VEGF in the angiogenic development of early stagelengths for BCEs plated on Matrigel (Becton Dickinson, Bedford, MA) and
the individual OPN isoforms and pCMV empty vector controls. H153 and
N expression. OPNa overexpression in all cell lines resulted in significantly
cantly increased tubule length in all cell lines compared with controls, but to
in tubule formation compared with controls in all 4 NSCLC cell lines. OPN,
gery c June 2010
FIGURE 4. A, Bar graft depicting the effect of the overexpression of individual OPN isoforms compared with pCMV empty vector controls on mean BCE
tubule length (m) in 4 NSCLC cell lines. Asterisk denotes a significant difference between OPN isoform overexpression in cell lines and pCMV controls. Mean
tubule length  standard deviation and P value are listed below bar graft. H153 and H358 wild-type cells had significantly shorter BCE tubule lengths than
A549 and H460, which have high native OPN expression. Tubule formation was significantly increased in all cell lines with forced overexpression of OPNa
and OPNb compared with controls. Conversely, overexpression of OPNc resulted in significantly fewer tubules formed compared with controls in all cell
lines. B, Bar graft depicting associated changes in VEGF secretion (picograms/milliliter) with overexpression of individual OPN isoforms compared with
pCMV empty vector controls in 4 NSCLC cell lines. Asterisk denotes a significant difference between OPN isoform and pCMV controls. Mean VEGF con-
centrations standard deviation andP value are listed below bar graft. H153 and H358 have low native OPN expression, and A549 and H460 have high native
OPN expression. Significant increases in VEGF secretion were associated with OPNa overexpression compared with controls. Conversely, OPNc overex-
pression was associated with significant decreases in VEGF secretion compared with controls in all cell lines. OPNb overexpression was associated with
no significant change in VEGF secretion in any of the 4 cell lines. C, Bar graft depicting the effect of the overexpression of individual OPN isoforms compared
with pCMV empty vector controls on OPN secretion (nanograms/milliliter) in 4 NSCLC cell lines. Asterisk denotes a significant difference between OPN
isoform overexpression in cell lines and pCMV controls. Mean OPN concentrations  standard deviation and P value are listed below bar graft. In H153,
H358, and H460 overexpression of OPNa and OPNb had no significant impact on OPN protein concentrations in conditioned media. In A549, overexpression
of OPNa and OPNb caused significant step-up in OPN protein secretion. Overexpression of OPNc caused a significant increase in OPN secretion in all cell
lines. OPN protein is measured by ELISA, which is not isoform specific. OPN, Osteopontin; NSCLC, non–small-cell lung cancer; BCE, bovine capillary
endothelial; VEGF, vascular endothelial growth factor; ELISA, enzyme-linked immunosorbent assay.
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by concurrent up-regulation of OPN.10
OPN and VEGF are known to act synergistically via avb3
integrin on the endothelial cell surface. Exposure to VEGF
increases avb3 expression, allowing for increased endothe-
lial cell migration in the presence of OPN.11 The avb3 integ-
rin is up-regulated in NSCLC tumors compared with normal
tissue, and antibody-mediated inhibition of this integrin re-
sults in endothelial cell apoptosis and restricted inva-
sion.23,24 This common pathway for OPN and VEGFThe Journal of Thoracic and Carcould serve as an important target for the regulation of
malignant behavior in NSCLC.10
We have demonstrated on an in vitro angiogenesis plat-
form that overexpression of the individual OPN isoforms
has a divergent impact on angiogenic properties in NSCLC.
OPNa increases BCE tubule formation, whereas OPNc
reduces tubule length. We have also demonstrated that
OPNa overexpression is associated with increased VEGF
secretion and expression, whereas OPNc is associated with
decreased VEGF secretion and expression, particularly indiovascular Surgery c Volume 139, Number 6 1591
FIGURE 5. Gene-array analysis demonstrated OPNa overexpression was
associated with a 2-fold increase in relative expression of VEGF, whereas
OPNc overexpression was associated with a 40% decrease in VEGF expres-
sion compared with controls. RT-PCR validation of gene array with regard
to divergent VEGF expression with overexpression of the OPN isoforms is
shown. Overexpression of OPNa in all 4 cell lines resulted in elevated
VEGF mRNA expression, whereas OPNc overexpression decreased
VEGF expression in all cell lines compared with wild-type cells. Elevated
VEGF mRNA expression was appreciated in control cell lines with high na-
tive OPN expression (A549 and H460) compared with cell lines with low
native OPN expression (H153 and H358). OPN, Osteopontin; VEGF, vas-
cular endothelial growth factor; PPIA, peptidylprolyl isomerase A.
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gest that some of the angiogenic properties conferred by
OPN may be due to modulation of VEGF production by tu-
mor cells. Studies that initially described the BCE platform
used in our experiments noted a relationship between VEGF
activity and increased tubule formation.25 Enhanced capil-
lary tubule formation with simultaneous increases in
VEGF secretion by NSCLC cells that overexpress OPNa
in our experiments is consistent with these observations.
We also noted that wild-type NSCLC cell lines with high en-
dogenous OPN (A549 and H460) had higher endogenous
VEGF secretion and greater angiogenic potential measured
by BCE tubule formation compared with wild-type cell lines
with low endogenous OPN (H153 and H358). However,
OPNb overexpression increased BCE tubule length without
associated changes in VEGF secretion or expression, indi-
cating that additional pathways are likely important, and fur-
ther demonstrating that each isoform has a unique effect in
this complex process. Senger and colleagues11 demonstrated
OPN’s ability to increase endothelial cell migration via bind-
ing to the avb3 integrin. It is reasonable to assume that
OPNb has the ability to activate endothelial receptors via1592 The Journal of Thoracic and Cardiovascular Surbinding to avb3 integrin, which would result in increased tu-
bule formation observed in these experiments, but it does so
without a concomitant augmentation of VEGF secretion or
expression by tumor cells. This ‘‘2-hit’’ effect on angiogen-
esis is likely exclusive to the full-length protein.
The relationship between overexpression of OPNa and
increased tubule formation was not linear. This is best appre-
ciated in H460 (high endogenous OPN), where overexpres-
sion of OPNa significantly increased tubule formation
compared with controls, but to a smaller extent than in
H358 (low endogenous OPN) (Figure 4). VEGF and OPN
are known to act synergistically via avb3 integrin to increase
angiogenesis in NSCLC. A similar nonlinear increase in
endothelial cell migration has been noted with exposure of
increasing concentrations of the 2 mediators.11 Cell lines
with low endogenous OPN expression demonstrated a larger
percentage increase in tubule length with overexpression of
OPNa, but a smaller increase in VEGF secretion, compared
with cell lines with high native OPN. This may indicate that
the introduction of OPNa into a system without endogenous
OPN may have a greater impact on endothelial cell activa-
tion than increasing expression in the presence of already
high levels of OPNa.
The impact of OPNc overexpression, which decreased
VEGF secretion and tubule length, appeared more linear.
Cell lines with high endogenous OPN had relatively large de-
creases in tubule length and VEGF secretion compared with
cell lines with low endogenous OPN in the presence of the c-
isoform. OPNc seems to act as a dominant negative in this
system, overriding the effects of the native OPN isoforms.
Our data suggest that OPN’s effect on tumor angiogenesis
is multifactorial and that each OPN isoform has a unique
effect. OPNa, the full-length protein and dominant isoform
expressed in NSCLC cell lines, increases angiogenesis by
activating endothelial cells, likely via binding to the avb3
integrin, with associated increases in VEGF secretion by
the tumor cells. OPNb, which has a deletion at exon-5,
seems to activate endothelial cells but does not increase
VEGF secretion by tumor cells. Neither OPNa nor OPNb
overexpression resulted in significant increases in OPN pro-
tein secretion, indicating that the effects in endothelial cell
activation are not merely due to the presence of more OPN
protein. OPNc, which lacks exon-4, has a dominant negative
effect in the system, decreasing endothelial cell activation
and VEGF secretion by the tumor cells. This supports our
hypothesis that individual OPN isoforms have divergent
roles with respect to tumor-associated angiogenesis and
VEGF production in NSCLC. The proangiogenic properties
of OPN function in an isoform-specific manner, and this
phenomenon is most pronounced in the OPNa isoform.
Structural similarities between OPNa and OPNc, which be-
have divergently, may make OPN ideal for isoform-specific
targeted therapies aimed at reducing the angiogenic potential
of NSCLC.gery c June 2010
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to evaluate isoform-specific inhibitory effects of OPN on
VEGF expression, secretion, and endothelial cell activation
because of the lack of isoform-specific antibodies currently
available. Our laboratory is currently working on production
of such antibodies. Future experiments include silencing
RNA in cell lines with high endogenous OPN to further
define the role of OPN on tumor angiogenesis. The lack of
quantitative PCR or gene array data from all transfected
cell lines weakens our findings with respect to isoform-spe-
cific mRNA expression.CONCLUSIONS
These in vitro data demonstrate that OPNa confers greater
angiogenic properties with increased BCE tubule formation
and an associated increase in secretion of VEGF in NSCLC.
OPNb, which lacks exon-5, activates endothelial cells, but
has no effect on VEGF secretion. OPNc, which lacks
exon-4, has a dominant negative effect, decreasing tubule
length and VEGF secretion. OPNa is the isoform preferen-
tially up-regulated in NSCLC cell lines. An enhanced under-
standing of the specific behavior of these subunits may lead
to therapeutic strategies that selectively inhibit OPN iso-
forms to alter the angiogenic and metastatic potential of
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